Oscar Health, Inc.
NYSE:OSCRMedical - Healthcare Plans
+$0.05 today
- Market cap
- $7.15B
- Beta
- 2.39
- P/E (TTM)
- -214.2
- EPS (TTM)
- -$0.13
Volume 7.38M
Average 7.51M
OSCR Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Oscar Health, Inc.NYSE: OSCR
Free Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Free cash flow growth accelerates
Q2 FY2026 free cash flow of $2.04B rose 307.3% year over year, ahead of the +260.8% change in trailing-twelve-month free cash flow. Sequentially, it fell 22.0% from the prior quarter. Over 3 fiscal years it compounded at +44.4% a year.
Context
- Free cash flow amounted to 9.0% of revenue in FY2025, down 1.3 pp from a year earlier.
- Free cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +307.3% holds above the trailing-twelve-month pace of +260.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 1.06B USD
- Year-over-year change
- +11.4%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.06B | +11.4% |
| FY2024 | 2024-12-31 | 950.3M | +419.2% |
| FY2023 | 2023-12-31 | (297.74M) | -184.7% |
| FY2022 | 2022-12-31 | 351.34M | +269.2% |
| FY2021 | 2021-12-31 | (207.63M) | — |
Free Cash Flow vs competitors
How OSCR compares with its peers on the latest reported figures
- OSCR's LTM Jun 2026 free cash flow of $4.33B is the 5th largest of the 8 companies compared; the peer median is $6.51B.
- Its year-over-year change of +260.8% is the 3rd highest of 8, against a peer median of +146.0%.
- Free cash flow amounts to 28.3% of revenue for OSCR, versus a peer median of 3.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $11.76B | +146.0% | -16.6% | 2.8% | |
| LTM Jun 2026 | $8.97B | +730.4% | -6.3% | 4.6% | |
| LTM Sep 2026 | $8.27B | +11.1% | +4.5% | 2.9% | |
| LTM Sep 2026 | $6.51B | +72.9% | -24.1% | 3.2% | |
| LTM Jun 2026 | $4.33B | +260.8% | +44.4% | 28.3% | |
| LTM Sep 2026 | $238M | +141.5% | — | 0.5% | |
| LTM Mar 2026 | $236.63M | +1140.5% | — | 5.6% | |
| LTM Jun 2026 | $74.21M | +254.0% | -30.8% | 3.0% | |
| Peer median (excluding OSCR) | $6.51B | +146.0% | -16.6% | 3.0% | |
Competitors are the stored peer set for OSCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (571.43M) | (609.55M) | (270.59M) | 26.12M | (442.9M) |
| Depreciation & Amortization | 14.61M | 15.28M | 30.69M | 32.15M | 28.89M |
| Deferred Income Tax | (101K) | (165K) | 58K | (2.34M) | 2.45M |
| Stock-Based Compensation | 86.3M | 112.33M | 159.68M | 109.82M | 87.65M |
| Change in Working Capital | 247.7M | 855M | (192.09M) | 838.86M | 1.46B |
| Accounts Receivables | 80.45M | (551.15M) | 636.23M | (177.52M) | 98.57M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (39.46M) | 280.23M | (395.81M) | 133.09M | 167.72M |
| Other Working Capital | 206.71M | 1.13B | (432.51M) | 883.29M | 1.19B |
| Other Non-Cash Items | 41.19M | 7.46M | 86K | (26.42M) | (40.24M) |
| Operating Cash Flow | (181.75M) | 380.35M | (272.16M) | 978.19M | 1.09B |
| Capital Expenditures | (25.89M) | (29.01M) | (25.58M) | (27.9M) | (36.37M) |
| Acquisitions (Net) | 7.23M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (1.81B) | (1.19B) | (836.98M) | (2.13B) | (1.01B) |
| Sales of Investments | 1.05B | 994.08M | 1.44B | 770.04M | 804.96M |
| Other Investing Activities | (555K) | 1.12M | (2.28M) | 3.93M | 4.28M |
| Investing Cash Flow | (774.52M) | (226.52M) | 577.19M | (1.39B) | (241.06M) |
| Debt Repayment | (153.17M) | 305M | 0 | 0 | 348.21M |
| Common Stock Issued | 1.35B | 1.3M | 3.96M | 68.39M | 55.03M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 43.56M | (5.19M) | 2.49M | 0 | (4.04M) |
| Financing Cash Flow | 1.24B | 301.11M | 6.45M | 68.39M | 399.21M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 282.45M | 454.94M | 311.47M | (340.85M) | 1.25B |
| Free Cash Flow | (207.63M) | 351.34M | (297.74M) | 950.3M | 1.06B |
Oscar Health, Inc.
NYSE:OSCR
Intrinsic Alpha fair value
Locked
Current Price
$27.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.